Low breast density and peritumoral edema on MR predict worse overall survival of breast cancer patients after neoadjuvant chemotherapy
Copyright © 2024 Elsevier B.V. All rights reserved..
OBJECTIVES: To investigate the relationship of pre-treatment MR image features (including breast density) and clinical-pathologic characteristics with overall survival (OS) in breast cancer patients receiving neoadjuvant chemotherapy (NAC).
METHODS: This retrospective study obtained an approval of the institutional review board and the written informed consents of patients were waived. From October 2013 to April 2019, 130 patients (mean age, 47.6 ± 9.4 years) were included. The univariable and multivariable Cox proportional hazards regression models were applied to analyze factors associated with OS, including MR image parameters and clinical-pathologic characteristics.
RESULTS: Among the 130 included patients, 11 (8.5%) patients (mean age, 48.4 ± 11.8 years) died of breast cancer recurrence or distant metastasis. The median follow-up length was 70 months (interquartile range of 60-85 months). According to the Cox regression analysis, older age (hazard ratio [HR] = 1.769, 95% confidence interval [CI]): 1.330, 2.535), higher T stage (HR = 2.490, 95%CI:2.047, 3.029), higher N stage (HR = 1.869, 95%CI:1.507, 2.317), low breast density (HR = 1.693, 95%CI:1.391, 2.060), peritumoral edema (HR = 1.408, 95%CI:1.078, 1.840), axillary lymph nodes invasion (HR = 3.118, 95%CI:2.505, 3.881) on MR were associated with worse OS (all p < 0.05).
CONCLUSIONS: Pre-treatment MR features and clinical-pathologic parameters are valuable for predicting long-time OS of breast cancer patients after NAC followed by surgery. Low breast density, peritumoral edema and axillary lymph nodes invasion on pre-treatment MR images were associated with worse prognosis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:171 |
---|---|
Enthalten in: |
European journal of radiology - 171(2024) vom: 01. Feb., Seite 111294 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yang, Zhenlu [VerfasserIn] |
---|
Links: |
---|
Themen: |
Breast density |
---|
Anmerkungen: |
Date Completed 14.02.2024 Date Revised 14.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ejrad.2024.111294 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367086107 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367086107 | ||
003 | DE-627 | ||
005 | 20240214233111.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240114s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ejrad.2024.111294 |2 doi | |
028 | 5 | 2 | |a pubmed24n1293.xml |
035 | |a (DE-627)NLM367086107 | ||
035 | |a (NLM)38218065 | ||
035 | |a (PII)S0720-048X(24)00010-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yang, Zhenlu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Low breast density and peritumoral edema on MR predict worse overall survival of breast cancer patients after neoadjuvant chemotherapy |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.02.2024 | ||
500 | |a Date Revised 14.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Elsevier B.V. All rights reserved. | ||
520 | |a OBJECTIVES: To investigate the relationship of pre-treatment MR image features (including breast density) and clinical-pathologic characteristics with overall survival (OS) in breast cancer patients receiving neoadjuvant chemotherapy (NAC) | ||
520 | |a METHODS: This retrospective study obtained an approval of the institutional review board and the written informed consents of patients were waived. From October 2013 to April 2019, 130 patients (mean age, 47.6 ± 9.4 years) were included. The univariable and multivariable Cox proportional hazards regression models were applied to analyze factors associated with OS, including MR image parameters and clinical-pathologic characteristics | ||
520 | |a RESULTS: Among the 130 included patients, 11 (8.5%) patients (mean age, 48.4 ± 11.8 years) died of breast cancer recurrence or distant metastasis. The median follow-up length was 70 months (interquartile range of 60-85 months). According to the Cox regression analysis, older age (hazard ratio [HR] = 1.769, 95% confidence interval [CI]): 1.330, 2.535), higher T stage (HR = 2.490, 95%CI:2.047, 3.029), higher N stage (HR = 1.869, 95%CI:1.507, 2.317), low breast density (HR = 1.693, 95%CI:1.391, 2.060), peritumoral edema (HR = 1.408, 95%CI:1.078, 1.840), axillary lymph nodes invasion (HR = 3.118, 95%CI:2.505, 3.881) on MR were associated with worse OS (all p < 0.05) | ||
520 | |a CONCLUSIONS: Pre-treatment MR features and clinical-pathologic parameters are valuable for predicting long-time OS of breast cancer patients after NAC followed by surgery. Low breast density, peritumoral edema and axillary lymph nodes invasion on pre-treatment MR images were associated with worse prognosis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Breast density | |
650 | 4 | |a Breast neoplasms | |
650 | 4 | |a Magnetic resonance imaging | |
650 | 4 | |a Neoadjuvant therapy | |
650 | 4 | |a Survival | |
700 | 1 | |a Wang, Nanzhu |e verfasserin |4 aut | |
700 | 1 | |a Han, Rongcheng |e verfasserin |4 aut | |
700 | 1 | |a Tang, Yu |e verfasserin |4 aut | |
700 | 1 | |a Chen, Hailan |e verfasserin |4 aut | |
700 | 1 | |a Xie, Yuhong |e verfasserin |4 aut | |
700 | 1 | |a Wang, Rongpin |e verfasserin |4 aut | |
700 | 1 | |a Tang, Lei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of radiology |d 1993 |g 171(2024) vom: 01. Feb., Seite 111294 |w (DE-627)NLM012952397 |x 1872-7727 |7 nnns |
773 | 1 | 8 | |g volume:171 |g year:2024 |g day:01 |g month:02 |g pages:111294 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejrad.2024.111294 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 171 |j 2024 |b 01 |c 02 |h 111294 |